INTRODUCTION
Injecting drug use is a major route of transmission for HIV in the United States (Centers for Disease Control and Prevention, 2002; Centers for Disease Control and Prevention, 2003) , and women who inject drugs are at significant risk of infection (Davis et al., 1998; Freeman et al., 1994; Hader et al., 2001; Prevots et al., 1996) . Of the more than 150,000 AIDS cases reported among women nationwide, through December 2002, injecting drug use accounted directly for 39% of cases (Centers for Disease Control and Prevention, 2003) . Early research among predominantly male injection drug users (IDU) documented risk factors for HIV infection, including frequency of injection, number of injections shared or needle sharing, early age of initiation, cocaine injection, and shooting gallery attendance (Chaisson et al., 1989; Chitwood et al., 1995; Friedland et al., 1985; Moss et al., 1994; Schoenbaum et al., 1989; Vlahov et al., 1990) . Later studies, however, suggested that female and male IDU engaged in injection risk behavior differently (Bennett et al., 2000; Dwyer et al., 1994; Gollub et al., 1998; Miller and Neaigus, 2001 ) and that risk factors for HIV infection among IDU differed between the sexes (Bruneau et al., 2001; Kral et al., 1997; Strathdee et al., 2001; van Ameijden et al., 1999) . Studies reporting exclusively on HIV transmission in female IDU detected additional risk among women of color (Magura et al., 1993; Watters et al., 1994) , women who engaged in prostitution (Astemborski et al., 1994; Watters et al., 1994) , who were out of drug treatment (Bruneau et al., 2001) , and who had a history of sexually transmitted disease Watters et al., 1994) . However, far less is known about the determinants of HIV-related risk behavior among female injectors since the establishment in the U.S. of syringe exchange programs (SEPs).
SEPs are one public health strategy to prevent the transmission of HIV for persons who reuse contaminated syringes for drug injection (Centers for Disease Control and Prevention, 2001) . In
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4 contrast with most other industrialized nations, there has been substantial political opposition to SEPs in the U.S., including a federal funding ban that prohibits using government monies to support these programs and State paraphernalia laws that hamper operation by criminalizing syringe possession or distribution (Jaffe, 2004; Lurie, 1995; Vlahov et al., 2001 ). Operating in a tenuous legal and political climate, SEPs have nonetheless received the support of volunteers, community based organizations and some local governments and, since their establishment in the U.S. in 1982, they have served increasing numbers of IDU (Bluthenthal et al., 1998; . San Francisco's SEP was launched in 1988 by a group of volunteers, and it is now one of largest and oldest in the U.S., operating legally since 1993, when the local government declared a public health emergency.
Many cities with SEPs have reported decreases in HIV incidence in IDU Gibson et al., 2001) . In San Francisco, HIV incidence among IDU declined from 3.9 per 100 person years of observation (PYO) to 1.2 per 100 PYO by 1990 (Moss et al., 1994) .
However, no reductions in HIV prevalence among IDU in San Francisco (range 8-10%) have been documented in the last ten years (Kral et al., 2001; Watters, 1994) . Reports of continued syringe sharing by SEP clients are not uncommon (Paone et al., 1997; Valenciano et al., 2001; Wood et al., 2002) . Most studies of SEP clients report on predominantly male populations, although one study of female exchangers reported elevated injection risk behaviors among sex workers . A better understanding of factors associated with syringe sharing among female SEP users can inform interventions to reduce further the transmission of HIV and other blood borne pathogens among female IDU.
In July 1995, the San Francisco AIDS Foundation's HIV Prevention Project (SFAF-HPP) launched an indoor women-only SEP site and, in 1997, SFAF-HPP contacted the authors to Author Version 5 request a program evaluation to assess and improve SEP services for female IDU. We subsequently interviewed a sample of female IDU recruited from the women-only and mixedgender SEP sites in San Francisco. Although participants did not experience direct benefits from the study, we presented our findings to SFAF-HPP who used the data to inform planning decisions and enhance program-level services for female IDU. In this paper, we report on our data from the women-only and mixed-gender SEP sites. First, we describe the sociodemographic, health, and risk behavior characteristics of female syringe exchangers in San Francisco. Second, we examine factors associated with risky injection behavior in settings where SEPs are well established.
METHODS

Study Population
We recruited a stratified sample of female syringe exchangers for anonymous, cross-sectional interviews from all twelve sites of the SFAF-HPP in operation at the time of the study. For the purposes of the program evaluation, one-third of the study sample was recruited from streetbased SEPs, one-third from a storefront SEP, and one-third from an indoor SEP open to women.
The street-based SEPs were located in eight different neighborhoods throughout the city and each operated for a two-hour period, one day per week. The storefront SEP was located in the South of Market district and operated on three different weekdays, for two-hours per day. The womenonly SEP operated from an indoor location in the Mission district and was open for a two-hour period, one day per week. All of these SEPs offered syringe exchange, ancillary injection supplies (cotton, cookers, water, and bleach), condoms and referrals; the storefront and womenonly SEPs also offered on-site medical care.
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Study participants were recruited at the SEP sites by a member of the interview team. This team consisted of eight women, diverse in age and ethnicity, all of whom had prior outreach or interview experience with female drug users. After a potential study participant had completed her syringe exchange transaction, an interviewer approached the woman to describe the study and invite her to participate, explaining that participation was voluntary and not a condition of using SEP services. If the woman was interested in participating, the interviewer then screened for study eligibility. Eligibility criteria were self-reported age greater than 17 years, history of drug injection during the preceding 30 days, and syringe exchange at that site on the day of recruitment. A female IDU accompanying a male syringe exchanger was considered eligible if syringes he exchanged were also for her own use, and five women entered the sample under this eligibility criterion. A total of 190 women were recruited and 163 (86%) agreed to participate.
Most who declined cited lack of time, and they did not differ significantly from those who agreed to participate by observed ethnicity or recruitment venue. Two women chose to terminate the interview before completion and these interviews were subsequently excluded from analysis. An additional 12 interviews were excluded because of eligibility criteria or because they were repeated interviews, leaving a total sample size of 149. All interviews were conducted between May and September 1997.
Data Collection
After providing informed consent, participants accompanied the interviewer to a nearby quiet café or fast food restaurant to complete a 30-40 minute face-to-face survey. Data collection occurred during hours of SEP operations, so that the study sample was representative of persons attending SEPs. After completion, participants were offered $20 compensation for time spent in Author Version 7 the study, as well as referrals to medical care, drug and alcohol treatment, emergency housing, and other social services. All study procedures were approved by the Committee on Human
Research at the University of California, San Francisco.
Measures
The survey collected information on participants' demographics, health status, drug use, SEP utilization patterns, syringe sources, and sexual behavior. Questions were based on variables used in prior studies of SEP participants in San Francisco (Guydish et al., 1998; Guydish et al., 1995) with additional variables of interest submitted by an all-female community advisory board. The survey was pre-tested with 5 female IDU using the study procedures described above.
Sociodemographic variables included age, race, education, housing, residence with other IDUs ("do you live with anyone else who injects drugs"), and incarceration. Health variables included self-reported health status ("how do you rate your health?"), insurance status, health care utilization, HIV testing and infection status, and lifetime prevalence of selected medical conditions. We also collected data on recent (12-month) history of physical and sexual assault. Sexual behavior variables included the number, gender, and type of sex partners (main, casual, and sex-trade) in the last thirty days, as well as types of sex (vaginal, anal and oral sex) practiced in the last thirty days. We operationally defined "sex trade" as transactions in which vaginal, anal, or oral sex was traded for drugs, money, or a place to stay. Percent condom use in the preceding 30 days for oral, vaginal, and anal sex were assessed for sex with male partners.
Higher risk sexual behavior was defined as less than 100% condom use AND more than one sexual partner in the prior 30 days.
Statistical Analysis
Survey data were analyzed to describe the characteristics of female IDU attending SEPs and to examine factors associated with syringe sharing. Summary statistics included frequency tables for categorical variables and medians and interquartile ranges (IQRs) for continuous variables.
Continuous variables were categorized for frequency tables using logical cutoffs. Bivariate associations between predictor variables and outcome variables were analyzed using the ChiSquare test of association or Fisher's Exact test for small cell sizes. The Mantel-Haenszel ChiSquare was used to test ordinal bivariate associations. We examined the independent effects of Author Version 9 the predictor variables on recent needle sharing using multivariate logistic regression (Hosmer and Lemeshow, 1989) . Variables selected for inclusion in multivariate models were those found to have a Chi-Square p-value < 0.05 on bivariate analyses or considered potential confounders based on expected biologic and behavioral inference. Multivariate models were evaluated using logistic regression methods. The final model was constructed with significant predictors entered simultaneously. Adjusted odds ratios (ORs) and 95% confidence intervals are reported for the model. All statistical analyses were performed using the Statistical Analysis System (SAS) version 6.12 statistical package for IBM-PC.
RESULTS
Baseline Characteristics of Female Syringe Exchangers
Sociodemographics and health status. Among the 149 participants enrolled, the median age was 38 years (IQR = 28-45) and 50% were women of color (26% African American, 12% Latina, and 13% another non-white ethnicity, including 3% Native American, 1% Asian, 1% Pacific Islander, and 8% "Other Race"; Table 1 ). Most had a high school education and lived currently with another IDU. Nearly half were currently homeless, and as many had been incarcerated during the last two years. Most of the 63 homeless respondents reported currently staying in hotel rooms (37%), on the streets (33%) or with a friend (21%); a small proportion stayed with family (5%) or in a shelter (3%). Few (15%) participants reported full or part-time employment, while 63% reported illegal income sources. The most commonly reported income-generating strategies were under-the-table jobs (48%), drug sales (42%), prostitution (36%), and panhandling (35%).
Most respondents (83%) had previously been pregnant, although fewer (59%) reported having children of any age. Thirty seven percent had children under 18 years old, but of these 55 women, only 15 (27%) currently lived with their children. One third (33%) of women reported a physical assault and 11% percent reported a sexual assault in the prior year.
When asked to rate their health, few women (5%) reported excellent health status, and more than half (54%) reported either fair or poor health (data not shown). Two-thirds had no health
insurance, yet nearly all sought health care in the prior year, primarily from free clinics (68%) and emergency departments (63%), but also from SEPs offering medical care (33%). Nearly all (96%) women had been previously tested for HIV and most had received an HIV test within the last 12 months (Table 1 ). The median number of prior HIV tests was six (IQR=3-10). Nine women (6%) reported they were HIV-positive, half of whom had been diagnosed in the preceding year. Few respondents knew about hepatitis C virus (HCV), and only 22% reported known HCV infections. The most common prior health conditions were pregnancy (83%), injection-related skin and soft tissue infections (70%), drug overdose (59%), and sexually transmitted infections (STIs) (55%).
Drug use behavior. The median age of first injection was 20 years (IQR = 17-25), and 42% reported a family member injecting drugs while they were growing up. Many (73%) reported a history of drug treatment and methadone detox (47%), methadone maintenance (36%) and outpatient (34%) were the most commonly accessed modalities. Almost two-thirds (64%) had entered treatment voluntarily at least once, although 22% reported at least one treatment episode mandated by the criminal justice system. Few (14%) were in treatment at the time of interview and 54% reported interest in entering treatment if a slot were available. Most women were frequent heroin injectors (Table 2) . Most (62%) reported a main injecting partner, someone with whom they usually purchased, prepared, and injected their drugs. Several (36%) reported more than one injecting partner in the prior month. (11) 94 (63) 88 (59) 62 (42) 10 (59) 35 (37) 25 (28) 30 (48) .028 ns .
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Fifty-two participants (35%) reported sharing a syringe in the preceding 30 days (Table 2) . Of these, few (24%) consistently bleached their syringes between uses, and the majority (71%) used the syringe after their syringe-sharing partner (data not shown). Twenty-seven women (18%) reported sharing syringes on more than five occasions in the preceding 30 days, and 14 (9%)
reported more than one syringe-sharing partner. Many participants reported inconsistent cleansing of the injection site and ancillary equipment sharing in the prior 30 days, and this was highly correlated with recent syringe sharing ( Table 2) .
SEP utilization and syringe sources. Most women (83%) had been attending SEPs for more than one year, and many attended at least weekly (Table 2 ). They arrived primarily on foot (72%), followed by public transportation (16%) (data not shown). Respondents from the womenonly SEP spent significantly more time there than respondents from SEP sites that served men and women together (40 vs. 10 minutes; p=0.0001). On the day of recruitment, respondents exchanged an average of 33 needles (range=1-400). Most exchanged for themselves, but half (54%) also exchanged syringes for others. Respondents also reported obtaining other services at SEPs, including other safer injection supplies, i.e., cotton, alcohol wipes, bleach (91%), condoms (81%), emotional support (68%), food (38%), health care (33%), and clothing (23%).
SEPs were the sole source of new syringes for most participants, and the median number of syringes currently in possession was twenty (Table 2) . During the 16-week study period, women exchanged 172,000 syringes at SFAF-HPP sites (personal communication, SFAF-HPP). Half the women (53%) felt they had access to enough syringes to use a brand new needle for each injection, but few (33%) reported one-time use. Most women (67%) re-used their own syringes and deployed each an average of three times before it was discarded or exchanged. Correlates of Syringe Sharing. On bivariate analysis, sociodemographic variables associated with recent syringe sharing were age under 30 years, white race, living with another IDU, current homelessness, incarceration, recent sexual assault, having any children and having a family history of IDU (Table 1) . Education, employment, and illegal source of income were not significantly associated with recent needle sharing. Health variables associated with recent syringe sharing were history of an STI and an HIV test within the preceding year. A prior pregnancy was inversely associated with syringe sharing. Drug use variables associated with recent syringe sharing included injection of amphetamine, a main injecting partner, number of injecting partners, sharing ancillary injection equipment, and inconsistent skin cleansing prior to drug injection (Table 2) . Recent syringe sharing also was associated with obtaining new syringes from sources other than SEPs, possessing fewer syringes, and re-use of one's own syringes (Table 2 ). There was no association between recent syringe sharing and SEP exposure or frequency of SEP attendance. Sexual variables associated with recent syringe sharing included having an IDU sex partner in the prior thirty days (Table 3) . In a multivariate logistic regression model, recent syringe sharing was associated with younger age, current homelessness, and an IDU sex partner (Table 4) . 
DISCUSSION
In this study, female IDU in San Francisco were shown to have precarious dual risk for HIV infection, not only via contaminated injection equipment but also through sexual contact with IDU or other high-risk partners. Despite regular and frequent SEP use, one-third (35%) reported sharing a used syringe for drug injection in the prior month. This was higher than the rate of needle sharing (21%) reported by a mixed gender sample of San Francisco exchangers in 1993 (Sears et al., 2001) , although it resembled the rate (36%) reported by a mixed gender sample in 1992 (Guydish et al., 1998) . In our study, female syringe sharers were more likely to be young, homeless, and have a sexual partner who was also an IDU.
Previous research has identified young IDU as at high risk for HIV infection (Bailey et al., 2003; Guydish et al., 2000; Hahn et al., 2002) . Younger age has been consistently associated with higher rates of injection risk behavior and blood-borne infection (Battjes et al., 1992; Fennema et al., 1997; Fuller et al., 2004; Garfein et al., 1996; van Ameijden et al., 1993) and one study found that young women IDU in San Francisco engaged in injection-related risk behaviors at higher rates than young men IDU (Evans et al., 2003) . Our results suggest that the association of younger age and HIV risk persists among women who use syringe exchange programs. Young IDU are typically homeless runaways, who are often involved in the underground street economy. They make their living through prostitution, drug sales, theft, panhandling, pornography, or selling stolen property (Office of National Drug Control Policy, 2001). They often experienced a large number of negative events prior to leaving home and are more likely to have experienced traumatic life events, such as intergenerational drug abuse, forced institutionalization, and survival sex (Martinez et al., 1998) .
We found that the life experiences of female syringe exchangers in San Francisco commonly include intergenerational drug use, homelessness, pregnancy, and incarceration. Homelessness has been associated with HIV infection among IDU in other North American cities (Strathdee et al., 1997) , and we found an association between homelessness and continued syringe sharing in our study. State paraphernalia laws that criminalize the possession of syringes for illicit drug use may contribute to this risk factor by discouraging IDU to carry their own sterile syringes and homeless IDU may make practical choices to borrow syringes so as to avoid arrest for syringe possession.
Our finding that recent syringe sharing occurs more often among female syringe exchangers, who report sex with another IDU, highlights the complexity of dual risk for women who use drugs and the challenge this poses to HIV prevention programs. Previous research supports our finding that women's syringe sharing behavior is frequently embedded in sexual relations (Booth, 1995; Davies et al., 1996; Dwyer et al., 1994; Freeman et al., 1994; Gollub et al., 1998; Latkin et al., 1998; MacRae and Aalto, 2000; Sherman et al., 2001; Tortu et al., 2003) . As women have historically assumed positions of deference and care-giving in both drug-using networks and the larger society, it is unsurprising that most female syringe sharers in our study reported injecting after their drug-using partners with the same needle. In contrast to a study of female SEP clients in five U.S. cities , we found that participants engaging in sex work did not report greater injection risk than non-sex workers. Participants in Paone's study were more likely to be African-American, Latina, currently in drug treatment, and currently housed than participants in this study, and these differences may contribute to the different relationship between sex work and injection risk reported here.
There are several limitations to our analyses. First, our small sample size may have limited our power to detect small but potentially important differences between study groups. Second, while some studies have shown that self-reported data by IDU are valid, others have suggested that IDU underreport risk behavior, particularly those related to illegal activities McCusker et al., 1992) . Our use of trained female interviewers with extensive prior experience working with female drug users may have mitigated this bias. In addition, our sample's self-reported HIV prevalence of 6% is consistent with previously estimated rates for women drug users in San Francisco (SF-HPPC, 1996) and on the West Coast (Prevots et al., 1996) , supporting the validity of this self-reported data. Third, this study focused on one subset of female IDUs -female syringe exchangers -and additional research is needed to investigate the risk behaviors of female IDU who do not use SEP. Fourth, our analysis relied upon linear models which, although standard in the field, have recently been criticized as inappropriate for understanding the complex, multi-dimensional, and non-linear processes of substance abuse (Buscema, 1998; Buscema, 2002) . Finally, the data presented in this study were collected in 1997 and may not reflect the risk behaviors of women exchangers in San Francisco today. In particular, the women's needle exchange site described here closed in 2002, following budget cuts and decreased site utilization, possibly driven by major gentrification and the relocation of
IDUs to other neighborhoods. The ancillary services that were provided at the women's sites (free medical care, HIV testing, free food and outreach workers) are now provided at most San Francisco SEP sites. Despite these changing circumstances, this study contributes important data to the limited number of published studies of HIV-risk among female IDU who use SEPs.
While wide access to sterile syringes is an important strategy to reduce HIV transmission among IDU, syringe exchange alone cannot eradicate risky injection by female IDU. Many female SEP clients engage in selective risk taking, i.e., choosing to share syringes with sexual partners with whom they have steady relationships and with whom they also do not use condoms (Valente and Vlahov, 2001) . Interventions that address injection risk behavior between sex partners, as well as the potential influence of traditional gender roles, violence, and drug use needs on the dynamics of these relationships, are needed for young and novice female IDU.
These interventions might focus on negotiation and communication skills that promote sterile syringe use, as well as condom use, in a setting that promotes rather than challenges trust and intimacy. Syringe sharing in the era of needle exchange also appears to occur among those most vulnerable to infection, i.e., the young and homeless. On a structural level, interventions that address the greater health risks associated with new-onset injection and homelessness are also urgently needed. Programs that increase access to clean syringes may operate not only to reduce risk of infectious disease, but also as an avenue to drug treatment and other health and social services. For SEPs to succeed as a bridge to treatment, treatment systems may also require change to increase access and availability of services, and to reduce stigma associated with injection drug use. Policy initiatives mandating treatment as an alternative to incarceration for drug-involved offenders, like those currently operating in Arizona and California (Administrative Office of the Courts, 1999; Speiglman, Klein, Miller, & Noble, 2003) , offer one example of this type of system change.
Despite a host of competing concerns for active female injectors, SEPs in San Francisco have evolved into points of regular contact with most women visiting on a weekly basis. Few other HIV prevention programs report such regular voluntary attendance. SEPs, and femalefocused SEPs in particular, may offer an ideal community platform to apply new intervention strategies toward women drug users at continued risk.
